Jul 20, 2021 07:12 AM IST
Though Nifty has witnessed a sharp correction, it remains in an intermediate uptrend as long as it is trading above the important support level of 15,500, said Nandish Shah of HDFC securities.
- Apr 01, 2021 01:56 PM IST
By providing attractive valuations, the COVID-19 pandemic seems to have offered an opportunity to investors who have been eyeing the mid and small-cap space to place their bets at significantly low risk, say experts.
- Dec 11, 2019 08:25 AM IST
If 11,800 levels get violated decisively on the downside then we might witness further sell-off in prices towards 11,700 levels as well.
- Sep 26, 2018 01:50 PM IST
A sustained trade above 10,855 will trigger a short covering rally to levels of 11,205-11,410, says Aditya Agarwala of YES Securities
- Jun 25, 2018 08:29 AM IST
With challenges on the macro front and increasing political headwinds faced by the BJP heading into the 2019 general elections, Prabhudas Lilladher believes traders are likely to remain cautious
- Mar 21, 2018 09:35 AM IST
On any bounce in prices, the Nifty index will face strong resistance around 10,250-10,300 levels.
- Mar 21, 2018 08:36 AM IST
Trends on SGX Nifty indicate a flat to positive opening for the broader index in India, a rise of 4 points or 0.04 percent.
- Nov 28, 2017 10:42 AM IST
Eris Life, Whirlpool and Gujarat Gas, among others, are being tracked by investors on Tuesday.
- Nov 21, 2017 09:24 AM IST
NTPC, IndiGo and Quess Corp, among others, are on investors’ radar on Tuesday.
- Oct 05, 2017 11:16 AM IST
Moneycontrol ran an analysis of companies which generated consistently double-digit growth in cash flows in the last four fiscal years.
- Jul 13, 2017 04:26 PM IST
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
- Jun 16, 2017 10:01 AM IST
With a predominant focus on the domestic formulations market, a robust portfolio of largely prescription-based drugs, and a tilt towards a promising chronic portfolio, the company seems fundamentally strong.